• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    SAPA-GP 2025 Conference Highlights Biopharma Evolution

    BUSINESSWIRE

    IDBS Unveils Polar Control For Biopharma Process Management

    PR NEWSWIRE

    Madrigal To Join 45th Annual TD Cowen Health Care Conference

    GLOBENEWSWIRE

    Ensho Presents NSHO-101 Data For IBD At ECCO 2025

    GLOBENEWSWIRE

    Ardelyx to Present at TD Cowen Annual Health Care Conference

    GLOBENEWSWIRE

    India’s Biopharma Industry Urged To Be More Ambitious

    EXPRESSPHARMA

    Hepion Pharmaceuticals Announces $9.0 Million Public Offering

    GLOBENEWSWIRE

    Silo Pharma Files Patent For PTSD Treatment Innovation

    GLOBENEWSWIRE

    Talicia Gets Humana Coverage, New Simplified Dosing Data Published

    PR NEWSWIRE

    Sciwind Signs Global Licensing Deal for Metabolic Disease Portfolio

    PR NEWSWIRE

    Sionna Adds Dr. Marcella & Dr. Jo Viney to Board of Directors

    PR NEWSWIRE

    Tonix To Present At Two Investor Conferences This January

    GLOBENEWSWIRE

    ONL Therapeutics Appoints Penny Fleck as Chief Development Officer

    GLOBENEWSWIRE

    Argent BioPharma Ltd. Raised US$4,500,000

    PR NEWSWIRE

    Sling Therapeutics Appoints Andrew to its Board of Directors

    PR NEWSWIRE

    Beyond Air to Participate in Lytham Partners 2025 Investor Summit

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Present at 43rd J.P. Morgan Conference

    GLOBENEWSWIRE

    Halia Therapeutic Strengthen Leadership & Clinical Operation Team

    PR NEWSWIRE

    Ultragenyx Reports Inducement Grant Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    LakeShore Biopharma Updates Fiscal Year 2025 Guidance

    PR NEWSWIRE

    Day One to Present at 43rd J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Candel Therapeutics Closes Public Offering, Underwriter Option

    GLOBENEWSWIRE

    Ocular Reports Inducement Grant Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    NewAmsterdam Closes $479M Public Offering With Upsize

    GLOBENEWSWIRE

    Praxis Precision to Present at December Investor Conferences

    GLOBENEWSWIRE

    89bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Cue Biopharma Reports Inducement Grant Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    Soleno to Attend Piper Sandler 36th Annual Health Conference

    GLOBENEWSWIRE

    Syndax Announces Participation at Citi 2024 Healthcare Conference

    PR NEWSWIRE

    89bio to Participate in 7th Annual Evercore HealthCONx Conference

    GLOBENEWSWIRE

    Dynavax to Present at 7th Annual Evercore HealthCONx Conference

    PR NEWSWIRE

    UMDF & Khondrion Announce Investment to Advance Mitochondrial Drug

    GLOBENEWSWIRE

    BioAge Labs to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    Ultragenyx Reports Inducement Grant Under Nasdaq Rule 5635

    GLOBENEWSWIRE

    Biophama VC, deal values and exits all rise in Q3

    FIERCE BIOTECH

    BLOC Announces Board of Directors and Executive Council Formation

    GLOBENEWSWIRE

    Mereo BioPharma to Join Fireside Chat at Jefferies Conference

    GLOBENEWSWIRE

    Protalix BioTherapeutics Reports Q3 2024 Results & Updates

    PR NEWSWIRE

    MediciNova Gets Patent Allowance for MN-001 in Liver Triglyceride

    GLOBENEWSWIRE

    Avadel Pharma to Present at Jefferies London Healthcare Conf.

    GLOBENEWSWIRE

    Ventyx Bio to Participate in 3 Upcoming Investor Conferences

    GLOBENEWSWIRE

    Mereo Bio Reports Q3 2024 Financial Results & Corporate Update

    GLOBENEWSWIRE

    Ocular Therapeutix™ Appoints Namrata as Chief Business Officer

    GLOBENEWSWIRE

    Kodiak Sciences to Participate in Upcoming Investor Conferences

    PR NEWSWIRE

    Altimmune Appoints Life Industry Veteran Greg Weaver as CFO

    GLOBENEWSWIRE

    Altimmune Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    GLOBENEWSWIRE

    PolyPid to Attend Craig-Hallum Alpha Select Conference

    GLOBENEWSWIRE

    Cingulate Q3 2024 Results: $19.5M Increase for ADHD Drug

    GLOBENEWSWIRE

    Skye Bioscience Report Q3 2024 Financial Results & Highlights

    GLOBENEWSWIRE

    Athira Pharma Q3 2024 Results & Business Updates

    GLOBENEWSWIRE

    Enliven Therapeutics to Present at Jefferies London Conf.

    PR NEWSWIRE

    Avidity Biosciences Reports Q3 2024 Financials & Highlights

    PR NEWSWIRE

    Invivyd to Attend Guggenheim Healthcare Innovation Conference

    GLOBENEWSWIRE

    Terns Pharmaceuticals to Attend November Investor Conferences

    GLOBENEWSWIRE

    Soleno Therapeutics Reports Q3 2024 Financials & Updates

    GLOBENEWSWIRE

    MacroGenics to Participate in Upcoming Investor Conferences

    GLOBENEWSWIRE

    Praxis Precision Medicines to Attend 3 Nov Investor Conferences

    GLOBENEWSWIRE

    Kymera Therapeutics to Participate in Nov Investor Conferences

    GLOBENEWSWIRE

    SpringWorks Joins Guggenheim Healthcare Innovation Conference

    GLOBENEWSWIRE

    Keros Therapeutics to Present at ASH 2024 Annual Meeting

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.